survey in Italy showed that neonatal units associated with an HMB have higher rates of maternal breastfeeding on discharge. 12 Using these data, these authors argued that the introduction of DHM may serve to extend a culture of breastfeeding. Similarly, others have argued that DHM should be considered a supportive measure to mothers expressing milk for their preterm infants and have used it as part of package of measures to try to increase maternal breastfeeding rates 13 and promote a culture of using only human milk 14 on NICUs. However, anecdotally, concerns have been raised that the introduction of DHM to a NICU may in fact discourage maternal breastfeeding. 13, 14 In addition, the authors of one study have shown that promoting DHM can lead to an unintended decrease in the use of OMM, perhaps by providing an "acceptable alternative" to the initiation and maintenance of lactation. 15 There is thus uncertainty as to whether the further introduction of DHM will affect either positively or negatively on maternal breastfeeding rates in NICUs.
Two large trials in North America are currently addressing whether there are clinical benefits to infants of using DHM compared with formula. 16, 17 However, because these trials are both blinded, impacts on health professional or maternal behaviors will not be fully determined. Thus, the aim of this review was to strengthen the evidence base for the use of DHM and to determine the effects of DHM provision on measures of OMM use during admission and on breastfeeding rates at discharge. We addressed the following research question: in mothers with an infant admitted to a neonatal unit (population), what are the effects of using DHM (intervention) versus formula milk (comparison) on maternal breastfeeding rates in, and on discharge from, the NICU (outcome)? Given the complexity of DHM as an intervention, we anticipated there might be relatively few randomized controlled trials and that cluster trials and/or observational studies would require research synthesis.
Methods

Searches
This review and the manuscript reporting it was prepared according to the PRISMA guidelines, 18 and the completed PRISMA checklist is available in Supplementary Appendix S1, available online. We carried out a systematic literature review in October 2014 using the following databases: Medline, 19 Embase, 20 and Global Health 21 (all using the OVID interface) 22 ; The Cochrane Library 23 ; CINAHL 24 ; Global Health Library 25 ; and Current Controlled Trials. 26 Search terms were generated using MeSH and Emtree terms relating to breast milk, infant formula, milk banks, milk donation, and neonatal units, with input from a medical librarian. A complete list of search terms, formatted for each database, is available within the study protocol in Supplementary Appendix S2. The review is registered on PROSPERO 27 (CRD42014013162).
Databases were searched from 1946 onward. Only studies with abstracts published in the Latin alphabet were reviewed, and these were translated if necessary by one of the authors (T.W.). We conducted reference searches of the studies that met the inclusion criteria, carried out citation tracking of these studies via Google Scholar, 28 and contacted experts in the field in North America, Europe, and Australia to identify further relevant studies. Two reviewers (T.W. and J.S.) independently assessed the articles identified in the screening search using the inclusion and exclusion criteria.
Inclusion/Exclusion Criteria
Studies were included if (1) the study was original research, (2) the study was a controlled trial with participants allocated randomly or an observational trial examining the impact on maternal OMM provision or breastfeeding rates pre-and postintroduction of DHM to a neonatal unit, (3) the study population was infants admitted to a neonatal unit, (4) the study specifically compared enteral feeding with DHM versus formula, and (5) the study provided quantitative data on maternal breastfeeding rates during the admission or on discharge.
Studies were excluded if the patient population included infants in postnatal or pediatric wards or did not compare donor breast milk directly with formula. Study types that were excluded were (1) case reports or opinion pieces without primary data or (2) qualitative studies that did not provide data on the proportion of mothers' breastfeeding during the admission or on discharge.
Data Extraction, Assessment of Study Quality, and Risk of Bias
The following data were extracted from the studies meeting the inclusion criteria: authors, study setting and country where it took place, research question/study aims, definition of patient population, outcome measure, study sample size, rates of breast milk use prior to introduction of donor milk to a unit, and rates of breast milk use after the introduction of donor milk. Where data were given for breastfeeding rates on discharge, it was noted where this was on discharge from and the definition of the time period used (eg, within 48 hours of discharge). Data were entered onto Microsoft Excel (Microsoft Corporation, Redmond, WA, USA).
To assess the risk of bias within each individual study, we applied principles from the Cochrane Collaboration and the Working Group for Grading of Recommendations Assessment, Development and Evaluation. 29 Modifying a scoring system used previously by one of us, 30 we assessed the quality of each study as being high, moderate, or low, according to study design, sample size, quality of the control group, calculation of an odds ratio/relative risk, confounding factors, and the geographical spread of studies. Details of the scoring system can be found in Supplementary Appendix S3.
To assess the risk of bias across studies, we noted whether or not each study had been published in a peerreviewed journal. We contacted the principal authors of each included study to ascertain if they could share any unpublished data that might influence the cumulative evidence available. Finally, we contacted experts in the field to ensure there were no large data sets that were unavailable due to publication bias.
Data Analysis
Where data for breastfeeding rates after the introduction of DHM were directly comparable between studies, the numbers of infants in each group were aggregated and a relative risk (RR) with a 95% confidence interval (CI) was calculated. 31 The exposure for these calculations was the introduction of DHM to a neonatal unit. Where data were not comparable between studies, the outcomes before and after the introduction of DHM were extracted, and it was noted whether a summary measure had been calculated.
Results
Searches
Our database search yielded 374 records, and consultation with experts in the field identified 4 further studies. Citation tracking of studies that met the inclusion criteria yielded 25 additional records, and after excluding duplicates, a total of 286 studies were screened. Fourteen of these studies were selected for full-text review, of which 10 studies met the inclusion criteria ( Figure 1 ). Of the remaining 4, 1 was excluded as it duplicated data from an included study, 32 1 was not based in a neonatal unit, 33 1 did not compare breastfeeding rates before and after the introduction of DHM, 34 and 1 provided no quantitative data on breastfeeding rates. 35 Six of the included studies were based in the United Sta tes, 13, 14, [36] [37] [38] 43 2 in Spain, 39, 40 and 1 study in the United Kingdom 41 and Australia. 42 All the studies were published since 2008 but included data on infants born between 2001 and 2014. Table 1 provides a summary of the study characteristics.
Quality Assessment and Risk of Bias
The assessment of study quality is shown in Table 2 . One of the studies was judged to be of high quality, 39 7 of the studies were assessed to be of moderate quality, 14, [36] [37] [38] 40, 41, 43 and the remaining 2 13,42 to be of low quality. Only 1 study was prospective and interventional, 14 and only 2 included more than one hospital site. 13, 39 Two studies included DHM as part of a bundle of measures designed to increase maternal breastfeeding rates. 13, 14 Six were published in peer-reviewed journals, 13, 14, 36, 37, 39, 40 and 4 were conference abstracts. 38, [41] [42] [43] None of the contacted authors of the included studies shared unpublished data to contribute to our analysis. Consultation with experts in the field did not reveal any large unpublished data series relevant to this review.
Definitions
There was substantial heterogeneity in the definition of the patient population in the included studies. One study looked at infants born at < 30 weeks' gestation, 42 2 studies examined infants born at < 32 weeks' gestation or with a birth weight (BW) of < 1.5 kg, 13, 40 5 studies used a BW < 1.5 kg as the inclusion criteria, [36] [37] [38] 41, 43 1 study used BW < 2 kg, 14 and 1 study used BW < 1 kg. 39 Outcome definitions were similarly heterogeneous and were comparable in 4 studies for any breastfeeding on discharge 14, 39, 40, 43 and in 2 studies for exclusive breastfeeding on discharge 40, 42 and exclusive administration of OMM days 1 to 28. 37, 40 Only 1 study 40 defined a time period before discharge for the receipt of breast milk (48 hours), and none of the studies defined how that breast milk was given on discharge. Six studies did not document whether all infants or only surviving infants were used as the denominator for measures of maternal breastfeeding, 13, 14, 36, 38, 42, 43 3 excluded infants who died from their analysis, 37,40,41 and 1 study included these in the denominator. 39 When performing calculations, the denominators used were those given by the authors, and no adjustments were made for the infants who died, as these numbers were small.
Studies also varied in how DHM had been introduced to a neonatal unit. Three studies looked at changes in the administration of OMM after the introduction of a milk bank to a neonatal unit. [40] [41] [42] Two studies examined whether there was a change in practice after the introduction of DHM as part of a bundle aimed to increase the use of human milk. 13, 14 One examined changes in practice after a new policy specifying use of DHM when not enough OMM was available, 37 and the remaining 4 examined changes in practice after the introduction of DHM to a neonatal unit. 36, 38, 39, 43 
Effects of Introduction of DHM on Maternal Breastfeeding Rates
Two studies 40, 42 examined the effect of the introduction of DHM on exclusive maternal breastfeeding rates on discharge. One of these provided no definition of "exclusive breastfeeding" on discharge, and the studies included 2 different patient population groups (born at < 30 weeks 42 vs born at < 32 weeks or BW < 1.5 kg). 40 Aggregating the data showed no significant difference between the 2 groups, with an RR of 1.12 (95% CI, 0.91-1.40; P = .27) of breastfeeding on discharge after the introduction of DHM.
Four studies 14, 39, 40, 43 provided data on infants receiving any breastfeeding on discharge after the introduction of DHM. In one of these studies, 14 DHM was introduced as part of a program aimed to increase the volume of human milk given to infants born at less than 2 kg. No significant difference (P = .09) was found in infants receiving any breast feeds on discharge after the introduction of the program. No formal definition was given of "any breastfeeding on discharge" in this study. Another study 43 found a significant increase (P = .02) in any breastfeeding on discharge after the introduction of DHM milk to a neonatal unit. Patient population groups differed between the 4 study groups (BW < 2 kg, 14 < 1.5 kg, 43 < 1 kg 39 and born at < 32 weeks or BW < 1.5 kg). 40 Aggregating the data for the 4 studies, a significant difference was found between the 2 groups (RR, 1.19; 95% CI, 1.06-1.35; P = .005), showing an increase in maternal breastfeeding after the introduction of DHM.
Two studies 37, 40 examined the effect of the introduction of DHM on the exclusive administration of OMM in the first 28 days of life. One used a patient population of infants born at < 32 weeks, 37 and another looked at infants born at < 32 weeks or with a BW < 1.5 kg. 40 In the second study, there was a reduction (from 40% to 13%) in the percentage of infants receiving exclusive OMM. According to the authors, this was because after the introduction of DHM, it was used when there was not enough milk from the infants' own mothers, whereas prior to the introduction of DHM, infants were fed by parenteral nutrition the first days of their lives to avoid infant formula. Aggregating the data, no significant difference was found between the 2 groups (RR, 1.08; 95% CI, 0.78-1.49; P = .65). All the data above are shown in Supplementary Appendix S4.
Single studies provided data on a number of variables related to the use of OMM after the introduction of DHM Yes (2) None (2) Data from 1 unit (0) 6 (moderate)
Verd et al 39 Retrospective observational (0)
(1)
Demographic variables documented, no differences (2) Yes (2) None (2) Data from 4 units (2)
(high)
Abbreviations: DHM, donor human milk; OR, odds ratio; RR, relative risk.
( Table 1) . A single-center study judged to be of moderate quality found that the introduction of DHM was associated with a significant decrease in the percentage of feeds that were OMM days 1 to 14 (P < .01) and days 1 to 28 (P = .04) of life. 38 One study examined the percentage of exclusive OMM given until full feeds were established 41 and found no significant difference (P = .51) between the pre-and post-DHM groups. One study examined the percentage of feeds that contained > 50% OMM given to infants of up to 34 weeks corrected gestational age 36 and again found no difference between the groups (P = .95). Two studies looked at the percentage of OMM given (as volume) for days 1 to 14 13 and 1 to 28 of life, 37 respectively, but did not calculate a statistical summary measure.
Discussion
Interest in the use of DHM has increased over the past decade, manifest by a worldwide expansion in the number of HMBs. Despite this, there remains a relative lack of highquality research into the impact of DHM on the recipient neonatal population or its wider societal effects. Our systematic review of the use of DHM on maternal breastfeeding rates confirmed this lack of high-quality data, identifying only 10 studies that met the inclusion criteria. These studies were geographically limited, available from only 4 countries, and most of the included studies (6/10) were from the United States. Four of the 10 included studies were conference abstracts and were therefore not peer reviewed. Using a scoring system to assess study quality, only 1 was judged to be of high quality.
The available data demonstrate mixed effects on measures of maternal breastfeeding when DHM is introduced to a neonatal unit. Relative risk calculations with aggregated data from 4 studies did show a significant increase in any breastfeeding on discharge after the introduction of DHM. However, there appeared to be no effect on exclusive breastfeeding on discharge or the exclusive administration of OMM in the first 28 days of life after the introduction of DHM. Even where DHM was introduced as part of a care bundle (as it was in 2 of the included studies), 13, 14 in individual centers, there appeared to be no significant increase in measures of maternal breastfeeding. Conversely, 1 of the 10 studies showed a statistically significant decrease in the use of OMM after the introduction of DHM. 38 This was posited by the authors to be due to the fact that the provision of DHM was discouraging mothers from expressing breast milk. However, the remainder of the available evidence does not support the hypothesis that the introduction of DHM has an adverse effect on breastfeeding rates in NICUs.
Some of the heterogeneity in results may reflect the fact that DHM can be used in a variety of ways. One study described DHM as a "bridge" to be used until a mother is able to express enough milk for her preterm infant, 13 whereas others describe the rationale for DHM as being a way to reduce the volume of formula feeds being given to preterm infants 14 or as a means to more rapidly introduce enteral feeds. 40 Given that DHM is introduced for a variety of reasons and in a variety of ways (as part of package of measures, by opening an HMB, or by replacing preterm formula in feeding guidelines), it is perhaps not surprising that no consistent effect is seen on measures of maternal breastfeeding.
Limitations
Inclusion criteria and definitions of outcomes varied between the studies, precluding a formalized assessment of a risk of bias using a funnel plot. Where aggregated relative risks were calculated, study groups' patient populations differed in terms of birth weight and gestation, as well as whether they included infants who had died in their denominator, although the number of these was small. Our data samples were small for each variable, and the calculated intervals were wide, so that small but important effects in either direction could not be excluded for exclusive breastfeeding on discharge or use of OMM in the first 28 days of life. For other outcomes, the heterogeneity of study variables and patient populations limited the ability to meta-analyze the data. We are unable to comment on whether having consistent definitions of patient population and study outcomes would have supported a positive effect of DHM on other indicators of maternal breastfeeding success. However, it is likely that the larger data sets permitted by consistent definitions would have allowed a more definitive answer to the question of whether DHM affects these.
Eight of the 10 studies were retrospective, and there was a high risk of bias, with only 1 study judged to be of high quality. We attempted to rule out publication bias by contacting experts in the field to see whether substantial unpublished databases existed on this topic and could not find evidence for any. However, it remains possible that reports of trials with negative findings have not entered peer-reviewed journals or been accepted for conferences. In addition, we were unable to obtain unpublished data from the included studies on breastfeeding rates that may have influenced our results.
While we chose to concentrate on surrogate markers of how much OMM was provided during admission and on discharge, the introduction of DHM to a neonatal unit may affect other important outcomes. These include rates of OMM initiation, the duration of provision of OMM, the total proportion of human milk (ie, OMM and DHM) given to infants during their admission, the length of hospital admission, and practices related to the fortification of human milk. Thus, the narrow focus of our research question may limit the applicability of the findings of this systematic review.
Conclusion
In summary, the available data demonstrate positive effects on some, but not all, measures of maternal breastfeeding rates when DHM is introduced to a neonatal unit. There is also some evidence that in certain settings, rates might actually decrease. However, overall there is probably sufficient data available to reassure clinicians that the introduction of DHM in itself is unlikely to adversely affect breastfeeding rates. If the introduction of DHM is to be promoted as a cost-effective way of promoting maternal breastfeeding, further welldesigned studies with standardized populations, consistent use of DHM, measurable breastfeeding outcomes, and economic evaluation may help to inform uniformity of practice. Ideally, these could be integrated into large randomized controlled trials looking at the effects of DHM on clinical variables such as mortality, NEC, sepsis, and longer term health benefits.
